Related Experiment Video
Updated: Mar 16, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Failed cancer targets
1Cancer Research UK.
More than half of NHS England trusts missed the 85% target for cancer treatment within 62 days of urgent GP referral. This indicates significant delays in timely cancer care across the National Health Service.
Area of Science:
- Oncology
- Healthcare Management
- Public Health
Background:
- Timely cancer diagnosis and treatment are crucial for patient outcomes.
- National Health Service (NHS) England has established targets for cancer care pathways.
- Meeting treatment timeframes is a key performance indicator for cancer services.
Purpose of the Study:
- To report on the performance of NHS England trusts against the 62-day cancer treatment target.
- To identify the proportion of trusts failing to meet the 85% benchmark for urgent referrals.
Main Methods:
- Analysis of the latest performance figures from NHS England.
- Review of data on patients receiving treatment within 62 days of an urgent GP referral for suspected cancer.
Main Results:
- Over 50% of NHS England trusts did not achieve the 85% target.
- A significant number of patients experienced delays exceeding 62 days from urgent referral to treatment.
Conclusions:
- Current cancer treatment pathways in NHS England face significant challenges in meeting timely care standards.
- Urgent review and intervention are needed to address delays in cancer treatment initiation.
More Related Videos
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Cancer
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer-Critical Genes II: Tumor Suppressor Genes
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...